1. Show article details.

    BRIEF-UnitedHealth Provides Updates On Annual Shareholder Meeting, Board Actions

    Reuters – 6:52 AM ET 06/08/2022


  2. Show article details.

    UnitedHealth Group Provides Updates on Annual Shareholder Meeting, Board Actions

    Business Wire – 6:50 AM ET 06/08/2022

    UnitedHealth Group (UNH) provided updates on its 2022 annual shareholder meeting and actions by its Board of Directors. About UnitedHealth Group (UNH) UnitedHealth Group (UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses.

  3. Show article details.

    Surging drug prices targeted in U.S. study of pharmacy giants

    Reuters – 2:18 PM ET 06/07/2022

    The U.S. Federal Trade Commission is looking into how big pharmacy benefit managers like CVS Caremark affect pricing and patients' access to prescription drugs at a time when costs of some medicines, even older ones like insulin, have skyrocketed, the agency said Tuesday.

  4. Show article details.

    U.S. FTC launches inquiry into drug middlemen

    Reuters – 1:40 PM ET 06/07/2022

    The Federal Trade Commission said on Tuesday it will launch an inquiry into the prescription drug middleman industry, sending compulsory orders to six pharmacy benefit managers for records on their business practices. As part of the inquiry, the antitrust body will send orders to CVS Health Corp's Caremark, Humana Inc (HUM), Cigna Corp's Express Scripts and UnitedHealth Group's OptumRx, among others.

  5. Show article details.

    New Relic Adds Board Members as Part of Ongoing Board Refresh

    Business Wire – 5:00 PM ET 06/06/2022

    Pali Bhat, leading technologist at Reddit and formerly Google, recruited by company to join Board Kevin Galligan and Susan D. Arthur appointed to Board in connection with an agreement with JANA Partners LLC New Relic (NEWR), the observability company, today announced several updates related to its Board of Directors.

  6. Show article details.

    7 Best Dow Jones Stocks To Buy

    Benzinga – 12:57 PM ET 06/06/2022

    During periods of stock market volatility and economic uncertainty, it's reasonable for investors to want to take a more defensive approach with their portfolios. The 30 stocks in the Dow Jones Industrial Average are among the largest blue-chip companies in the U.S. market.

  7. Show article details.

    Merger Arbitrage Mondays – Bristol Myers (BMY) Acquires Third Point Therapeutics (TPTX)

    Benzinga – 11:09 AM ET 06/06/2022

    Another week and another deal with big pharma buying out a development stage oncology company. Turning Point Therapeutics  Headquartered in San Diego, Turning Point Therapeutics is a clinical-stage oncology company that specializes in the discovery and development of targeted cancer therapies designed to address treatment resistance.

  8. Show article details.

    Livindi and Fellowship Senior Living Launch Fellowship Connected Living

    Business Wire – 2:52 PM ET 06/01/2022

    Bringing exceptional health care services for clients living at home. Livindi, Inc. and Fellowship Senior Living are partnering to deliver the first-ever on demand in home care provider for families caring for older adults at home. This press release features multimedia.

  9. Show article details.

    UnitedHealth Group Whale Trades Spotted

    Benzinga – 10:12 AM ET 06/01/2022

    A whale with a lot of money to spend has taken a noticeably bearish stance on UnitedHealth Group. Looking at options history for UnitedHealth Group we detected 11 strange trades. If we consider the specifics of each trade, it is accurate to state that 9% of the investors opened trades with bullish expectations and 90% with bearish.

  10. Show article details.

    Expert Ratings for UnitedHealth Group

    Benzinga – 2:38 PM ET 05/27/2022

    Within the last quarter, UnitedHealth Group has observed the following analyst ratings: According to 12 analyst offering 12-month price targets in the last 3 months, UnitedHealth Group has an average price target of $590.0 with a high of $620.00 and a low of $549.00. Below is a summary of how these 12 analysts rated UnitedHealth Group over the past 3 months.

  11. Show article details.

    Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

    Benzinga – 11:36 AM ET 05/27/2022

    According to Bernstein, the prior rating for HCA Healthcare Inc was changed from Market Perform to Outperform. According to B of A Securities, the prior rating for O-I Glass Inc was changed from Neutral to Buy. According to Benchmark, the prior rating for iQIYI Inc was changed from Hold to Buy. iQIYI earned $0.03 in the first quarter, compared to $0.25 in the year-ago quarter.

  12. Show article details.

    Fortune 500 List Includes Cryptocurrency Company For The First Time; 30 Return After Missing 2021

    Benzinga – 9:56 AM ET 05/25/2022

    Fortune released its annual Fortune 500 list, ranking the largest companies in America by revenue. Cryptocurrency Earns Its Place: For the first time ever, a cryptocurrency company landed on the Fortune 500 List. A company needed to have 2021 revenue of $6.4 billion to enter the list, a mark that was up 19% from the previous year's list.

  13. Show article details.

    Pharmacy benefit managers' profits targeted by new U.S. bill

    Reuters – 1:16 PM ET 05/24/2022

    Senators Maria Cantwell, chair of the Commerce Committee, and Chuck Grassley, the top Republican on the Judiciary Committee, introduced a bill on Tuesday that would give the U.S. Federal Trade Commission more power to rein in pharmacy benefit managers, which administer pharmaceutical plans, Cantwell's office said.

  14. Show article details.

    Pharmacy benefit managers' profits targeted by new U.S. bill

    Reuters – 1:08 PM ET 05/24/2022

    Senators Maria Cantwell, chair of the Commerce Committee, and Chuck Grassley, the top Republican on the Judiciary Committee, introduced a bill on Tuesday that would give the U.S. Federal Trade Commission more power to rein in pharmacy benefit managers, which administer pharmaceutical plans, Cantwell's office said.

  15. Show article details.

    LHC GROUP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LHC Group, Inc. - LHCG

    PR Newswire – 6:20 PM ET 05/23/2022

    NEW ORLEANS, May 23, 2022 Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of LHC Group, Inc. (LHCG) to Optum, part of UnitedHealth Group.

  16. Show article details.

    Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 10 Years

    Benzinga – 2:03 PM ET 05/23/2022

    UnitedHealth Group has outperformed the market over the past 10 years by 12.8% on an annualized basis producing an average annual return of 24.26%. Currently, UnitedHealth Group has a market capitalization of $462.39 billion. Buying $100 In UNH: If an investor had bought $100 of UNH stock 10 years ago, it would be worth $877.76 today based on a price of $492.86 for UNH at the time of writing.

  17. Show article details.

    Merger Arbitrage Mondays - U.S. Defense Contractor ManTech International To Be Acquired By Carlyle

    Benzinga – 2:02 PM ET 05/23/2022

    Merger activity decreased last week with two new deals announced and three deals completed. ManTech International Corporation  Co-founded in 1968 by Franc Wertheimer and George J. Pedersen, ManTech International Corporation is an American defense contracting firm based in Herndon, Virginia. "The deliberations are part of Pedersen's estate planning, according to sources.

  18. Show article details.

    Check Out What Whales Are Doing With UNH

    Benzinga – 2:02 PM ET 05/23/2022

    Someone with a lot of money to spend has taken a bearish stance on UnitedHealth Group. And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know. So how do we know what this whale just did?

  19. Show article details.

    Merger Arbitrage Mondays - Chicken Soup For The Soul Acquires Redbox At a Massive Discount

    Benzinga – 3:33 PM ET 05/16/2022

    Most M&A observers had expected U.S. deal activity to moderate or drop sharply this year but it feels like things are heating up with large acquisitions like Microsoft's acquisition of Activision Blizzard or Elon Musk's acquisition of Twitter. Redbox Entertainment An interesting deal announced last week was the acquisition of Redbox Entertainment by Chicken Soup for the Soul Entertainment.

  20. Show article details.

    Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices

    Benzinga – 12:26 PM ET 05/13/2022

    Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices


Today's and Upcoming Events

  • Oct

    UNH to announce Q3 earnings (Unconfirmed)

  • Sep

    UNH ex-Dividend for $1.65 on 09/09/2022

    • Announce Date: 08/17/2022
    • Record Date: 09/12/2022
    • Pay Date: 09/20/2022

Past Events (last 90 days)

  • Jul

    UNH announced Q2 earnings.

  • Jun

    UNH ex-Dividend for $1.65 on 06/16/2022

    • Announce Date: 06/08/2022
    • Record Date: 06/20/2022
    • Pay Date: 06/28/2022
Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.

Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

See the Latest Features
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.